Category Archives: U.S. Policy and Funding

Report shows 1 in 10 medicines in low-and middle income countries are substandard, falsified

By on .

Antibiotics and antimalarial drugs are most frequently reported as substandard and falsified to the World Health Organization’s Global Surveillance and Monitoring system for such medical products, according to a WHO report released this week. The report estimates that one in ten medical products in low- and middle-income countries either fail to meet quality standards or […]

Exploration of geography with technology can open the health landscape and put services within reach

By on .

The following is a guest post by John Spencer of MEASURE Evaluation As a geographer, I believe it’s necessary to understand where things happen if you want to change the world. Are health facilities near the people who need them? Do diseases cluster in a specific place? Where should we direct resources after crises such […]

Analysis: Commitment to global health research, training, investment is critical to U.S. interests

By on .

The world was less connected then than it is now when the 1918 pandemic of HIN1 influenza broke out. Even then, by the time the outbreak ended two years later, it killed at least 50 million people around the world, from eastern Europe to the South Pacific, to the Arctic, taking 675,000 lives in the […]